Dr. Brady Lee Stein, MD

Dr. Stein practices at Northwestern Medicine Prentice Women's Hospital in Chicago, Illinois.

Dr. Stein's NPI, 1134275845, was assigned on January 26, 2007. Dr. Stein graduated from Emory University School of Medicine in 2003. Dr. Stein holds Illinois license 036-125922.

Dr. Stein's primary practice is Northwestern Medicine Prentice Women's Hospital, at 250 E Superior St, Chicago, IL 60611 in Cook County. The practice phone is (312) 472-3664.

Dr. Stein's primary practice is Northwestern Medicine Prentice Women's Hospital in Chicago, Illinois. Dr. Stein is also affiliated with Northwestern Memorial Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Stein to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stein practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Stein's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dmand AI has Dr. Stein's licenses on file in 2 states: Illinois and Maryland.

CMS data shows 27,536 Medicare services from Dr. Stein across 29 procedure codes in 2024, for 523 Medicare patients. Medicare paid $290,061 for them.

CMS counts 523 Medicare patients who saw Dr. Stein in 2024. The largest group is 65 to 74, with 216 patients. 74% of them have high cholesterol, and 70% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stein's median patient age at 67, with 60% women.

In 2024, Dr. Stein wrote 1,175 Medicare Part D claims for 218 patients. 40% of them were for generic drugs. CMS names the drug for 1,107 of them, across 10 drugs with 11 or more claims each, at $3,517,843 in total drug cost. In 2023, CMS named 1,112 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Stein for performance year 2024, reported through an alternative payment model (APM). Dr. Stein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stein as offering telehealth.

Dmand AI links 42 papers to Dr. Stein, published from 2015 to 2023. 2019 was the busiest year, with 7. The most frequent topics are Myeloproliferative Disorders, Janus Kinase 2 and Hematologic Neoplasms. Dr. Stein has published most often in Curr Hematol Malig Rep. Dr. Stein's most frequent co-authors are Ruben Anthony Mesa, MD, Michael Richard Grunwald, MD and Jason Gotlib, MD, MS.

CMS Open Payments shows 13 general payments to Dr. Stein from 3 drug and device companies from 2016 to 2020. Consulting fees make up the largest share, 69% of the total. Incyte Corporation paid the most, $12,060.

Dr. Stein graduated from Emory University School of Medicine in 2003.